Schedule 13G ownership disclosure

NEOS THERAPEUTICS INC

Security class unavailable · CUSIP: 64052L106

Event date: 2018-10-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,637,169
Percent of class
9.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-18-000600
Form type
SC 13G
Filer
Neos Therapeutics, Inc.
CIK
CIK 1467652
Filed
Nov 08, 2018
Reporting period
Oct 30, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub